Citadel Advisors - DICE THERAPEUTICS INC ownership

DICE THERAPEUTICS INC's ticker is and the CUSIP is 23345J104. A total of 78 filers reported holding DICE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of DICE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$2,721,116
-62.2%
58,569
-76.7%
0.00%0.0%
Q1 2023$7,205,246
+16.4%
251,492
+26.8%
0.00%0.0%
Q4 2022$6,188,676
-69.1%
198,355
-79.9%
0.00%
-80.0%
Q3 2022$20,057,000
+39.9%
988,966
+7.0%
0.01%
+25.0%
Q2 2022$14,338,000
+557.4%
923,849
+710.5%
0.00%
Q1 2022$2,181,000
-21.2%
113,985
+4.2%
0.00%
-100.0%
Q4 2021$2,768,000109,3560.00%
Other shareholders
DICE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
OUP Management Co., LLC 268,346$12,467,35521.26%
New Leaf Venture Partners, L.L.C. 371,693$17,268,85714.83%
RA Capital Management 7,856,612$365,018,1946.89%
NEXPOINT ASSET MANAGEMENT, L.P. 717,322$33,326,7804.86%
ALPINE ASSOCIATES MANAGEMENT INC. 2,116,800$98,346,5284.43%
KRYGER CAPITAL Ltd 880,756$40,919,9244.18%
Versor Investments LP 436,935$20,300,0003.52%
Crabel Capital Management, LLC 161,082$7,4843.09%
Twin Securities, Inc. 91,680$4,259,0002.36%
Vazirani Asset Management LLC 30,000$1,393,8002.35%
View complete list of DICE THERAPEUTICS INC shareholders